SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.

Daisuke KanaiHiromichi WakuiTatsuya HazeKengo AzushimaSho KinguchiShunichiro TsukamotoTomohiko KanaokaShingo UrateYoshiyuki ToyaNobuhito HirawaHideaki KatoFumimasa WatanabeKanako HanaokaMasaaki HanaokaHiroshi MitsuhashiSatoshi YamaguchiToshimasa OhnishiKouichi Tamura

Published in: Clinical and experimental nephrology (2022)

SARS-CoV-2 spike protein antibody titers were significantly lower in HD patients than in healthy controls at 1 (peak) and 6 months after the second vaccination. Low peak antibody titers contributed to low 6-month antibody titers.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
patients undergoing
chronic kidney disease
peritoneal dialysis
ejection fraction
binding protein
newly diagnosed
protein protein
prognostic factors
small molecule
patient reported outcomes